Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 4 4Phase NA 2Phase 1/2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 4Osteoporosis 3Pain 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 1Hypercalcemia 1Humoral Hypercalcemia Of Malignancy 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1

Interventions

Acupuncture Therapy 12Analgesia 11Therapeutics 8Psychiatric Rehabilitation 6Music Therapy 6Early Intervention, Educational 6Yoga 5Surveys and Questionnaires 5Water 4Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Morphine 4Methods 4Control Groups 4Colonoscopy 4Bupivacaine 4Aromatherapy 4Touch 3Standard of Care 3Saline Solution 3Physical Therapy Modalities 3Mindfulness-Based Stress Reduction 3Methadone 3Meditation 3Massage 3Exercise 3Electroacupuncture 3Cryotherapy 3Art Therapy 3Zoledronic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Pain × Zoledronic Acid × Clear all
NCT00458796 2022-05-27

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

University of Leeds

Phase NA Terminated
1,500 enrolled
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain, Breast Neoplasms, Male

NCT00126386 2011-11-21

Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community

AHS Cancer Control Alberta

Phase NA Completed
11 enrolled

Hypercalcemia, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡